SOLAR-PROMOTION-GMBH
25.5.2023 10:44:30 CEST | Business Wire | Press release
According to statistics from the European Alternative Fuels Observatory, over six million electric and hybrid cars were on Europe’s roads in 2022. From 2035 onward, all cars will have to be electric in the EU. With e-mobility booming, there is more and more potential for e-cars to be used as mobile energy storage systems. They can supply electricity to private homes and offices, stabilizing the public power grid in the process. Using vehicle batteries as flexible storage systems in a smart grid in the future will be a crucial step in guaranteeing a stable energy supply and a cost-effective way of achieving climate targets. Visitors at this year’s Power2Drive Europe, the international exhibition for charging infrastructure and e-mobility being held at Messe München on June 14–16, will be able to discover innovations in bidirectional charging. Experts will also be discussing this topic at the accompanying Power2Drive Europe Conference 2023 at the International Congress Center München (ICM).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230525005398/en/
Bidirectional Charging at an AC-Charging Station (Photo: Solar Promotion GmbH)
Electric cars are as environmentally friendly as the electricity that powers them. When doubled up as mobile storage systems, they can also supply private homes with clean energy. With bidirectional charging, for example with Vehicle2Home (V2H), it is possible to optimize the self-consumption of solar power and the costs associated with charging and discharging e-cars when electricity rates are variable.
Vehicle2Building (V2B) takes this concept one step further. Multiple vehicles supply electricity to residential buildings or commercial properties, ensuring that the energy required during peak loads doesn’t have to be sourced from the grid. Both V2H and V2B are behind-the-meter applications. This means that vehicles only feed the electricity back into the residential building or commercial property. “This generally makes Vehicle2Home much easier to implement than Vehicle2Grid. And users can already expect decent margins,” says Timo Kern, Head of Energy System and Markets at the Research Center for Energy Economics (FfE) in Munich.
“So many vehicles and homes are suitable for Vehicle2Home”
With e-mobility booming, there is growing potential for V2H. Vehicles sitting at home during the week because their owners are working from home, work part-time or have a flexible working agreement are ideal – as are cars belonging to commuters, which can be used to store surplus energy over the weekend. When they are parked at home in the evening after work, they can supply electricity to the home. The difference between the domestic electricity price and the photovoltaic feed-in tariff is another major factor: “Since this difference has become much greater with energy prices on the rise, lots of vehicles and homes are now suitable for Vehicle2Home,” says Kern.
Vehicle2Grid (V2G) also has the potential to mobilize the immense power reserves in millions of electric cars in a matter of seconds, helping to secure a stable power supply in the process. In this context, vehicle batteries are used as flexible storage systems in a smart grid, playing a crucial role in guaranteeing a stable energy supply and providing a cost-effective way of achieving climate targets. Think tank Agora Energiewende (German Energy Transformation Initiative) ran the calculations in its study Climate-Neutral Power System 2035. If a quarter of all electric cars use V2G in 2035 and 40 percent of those vehicles are made available to the electricity market on average, the usable output will amount to 28 gigawatts in Germany. V2G also has the potential to reduce dependence on battery storage systems in private homes and on large-scale battery storage systems. And there are benefits for car owners too... They have the opportunity to earn money when they offer some of their vehicle’s battery capacity as a power reserve.
Only a modest number of e-cars are used for bidirectional charging as it stands. As demand grows, however, there will be more and more opportunities for vehicles to be used as electricity storage systems – whether that’s for V2H, V2B, V2G or V2L (Vehicle2Load). Bidirectional wallboxes are still relatively rare for now too. But demand is on the rise here too, so it’s only a matter of time before the relevant charging solutions are readily available in the market. The European Union’s three-year SCALE (Smart Charging Alignment for Europe) project is helping to lay the foundations here, with smart charging solutions for electric vehicles being researched and tested in real-life scenarios. Another aim of the project is to clarify technical, organizational, economic and political uncertainties surrounding the introduction of smart charging, inter-operability and V2X (Vehicle2Everything) solutions. The ultimate goal is to create a new energy ecosystem that benefits from the flexibility of batteries in electric vehicles on a large scale.
Bidirectional charging at the exhibition and Power2Drive Europe Conference
Visitors at Power2Drive Europe 2023 will be able to discover innovations in bidirectional charging. As part of The smarter E Europe, the international exhibition for charging infrastructure and e-mobility will be showcasing products, innovations and business models relating to charging infrastructure and electromobility at Messe München from June 14–16. Over 300 suppliers of charging infrastructure solutions are set to attend The smarter E Europe. The Mobility House, KEBA Group, Alfen and EnerCharge are just some of the exhibitors who will be presenting their solutions for bidirectional charging in Hall B6.
The Power2Drive Europe Conference 2023 will start on the day before the exhibition at the International Congress Center München (ICM). Bidirectional charging will be in the spotlight alongside market trends, analysis and research findings, and innovative projects for electromobility and charging infrastructure. For example, the session called Bidirectional Charging: Energy Supply Challenges organized by consulting and engineering firm umlaut will be discussing the latest developments in bidirectional charging, presenting results from pilot projects and looking at potential barriers to scaling bidirectional charging.
The most recent episode on Vehicle2Grid – How Close Are We to V2G Becoming a Daily Reality? with Dr. Stefan Perras & Thomas Gereke from Siemens – offers an in-depth look at the role of V2G in the decentralized grid of the future.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230525005398/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
